| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |